Novel blood test could predict chronic lung disease in preterm babies within hours of birth

Plus, news about Mer­ck, Ori­on, Tonix, Freeflow and Y-mAbs Ther­a­peu­tics: Tra­con Phar­ma­ceu­ti­cals seeks ‘strate­gic al­ter­na­tives’ af­ter PD-L1 fails Ph2 tri­al: In an 82-per­son sar­co­ma study

This is a sidebar to a story on combined MD and DO state medical boards. For the main story, click here. If DOs fear they’d

A month af­ter re­veal­ing that its lead can­di­date had hit a dead end in in­flam­ma­to­ry dis­eases, Aclaris Ther­a­peu­tics will cut just un­der half of its